Stock ScreenerStock IdeasStrong Buys According to Wall StreetStrong Buys According to Wall StreetCompanies with high upside and a consensus strong buy recommendation from Wall Street analysts
Stock ScreenerStock IdeasStrong Buys According to Wall Street
Consensus: Strong Buy
Analysts: >= 3
Upside/Downside: Large Upside
| Ticker | Company | Zen Rating | Sentiment | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
|---|---|---|---|---|---|---|---|---|---|
| NTSK | NETSKOPE INC | $7.57B | 393,258,861 | 35.83% | 11.95% | Net Buying | |||
| TTAN | SERVICETITAN INC | $10.17B | 93,646,634 | 45.12% | 54.88% | Net Selling | Net Selling | ||
| EVEX | EVE HOLDING INC | $1.67B | 348,304,584 | 4.60% | 95.40% | Net Buying | Net Buying | ||
| AERO | GRUPO AEROMEXICO SAB DE CV | $3.11B | 1,459,034,090 | 0.00% | 0.00% | ||||
| JMIA | JUMIA TECHNOLOGIES AG | $1.58B | 244,925,650 | 11.33% | 0.00% | ||||
| BSVN | BANK7 CORP | $414.25M | 9,453,390 | 12.30% | 87.70% | Net Selling | Net Selling | ||
| FUFU | BITFUFU INC | $428.38M | 164,131,946 | 0.62% | 2.07% | ||||
| TDS | TELEPHONE & DATA SYSTEMS INC | $4.46B | 115,500,000 | 85.06% | 14.94% | Net Selling | Net Selling | ||
| AVTX | AVALO THERAPEUTICS INC | $337.29M | 18,133,968 | 15.86% | 84.14% | Net Selling | Net Selling | ||
| CNTA | CENTESSA PHARMACEUTICALS PLC | $3.34B | 134,447,836 | 90.30% | 9.70% | Net Selling | Net Selling | ||
| VOYG | VOYAGER TECHNOLOGIES INC | $1.61B | 59,547,781 | 35.05% | 4.41% | Net Buying | |||
| CBIO | CRESCENT BIOPHARMA INC | $164.63M | 13,892,516 | 13.39% | 86.61% | Net Buying | Net Buying | ||
| EVTL | VERTICAL AEROSPACE LTD | $554.82M | 99,787,293 | 69.34% | 4.12% | ||||
| KYTX | KYVERNA THERAPEUTICS INC | $314.89M | 43,796,170 | 50.31% | 49.69% | Net Buying | Net Buying | ||
| SMWB | SIMILARWEB LTD | $602.26M | 86,283,483 | 52.99% | 0.00% | ||||
| SAIL | SAILPOINT INC | $11.81B | 561,625,760 | 52.88% | 47.12% | Net Selling | Net Selling | ||
| JANX | JANUX THERAPEUTICS INC | $829.44M | 60,147,807 | 63.29% | 36.71% | Net Buying | Net Buying | ||
| ABCL | ABCELLERA BIOLOGICS INC | $1.08B | 299,335,048 | 34.75% | 44.84% | Net Buying | Net Buying | ||
| MGX | METAGENOMI INC | $66.08M | 37,546,751 | 15.98% | 34.26% | Net Buying | Net Buying | ||
| ICHR | ICHOR HOLDINGS LTD | $605.85M | 34,384,231 | 68.63% | 31.37% | Net Buying | Net Buying | ||
| TBPH | THERAVANCE BIOPHARMA INC | $952.13M | 50,672,431 | 52.91% | 47.09% | Net Selling | Net Selling | ||
| VIR | VIR BIOTECHNOLOGY INC | $801.36M | 139,125,032 | 67.50% | 32.50% | Net Selling | Net Selling | ||
| AMLX | AMYLYX PHARMACEUTICALS INC | $1.32B | 109,819,569 | 66.52% | 33.48% | Net Selling | Net Selling | ||
| XNCR | XENCOR INC | $1.11B | 71,410,469 | 72.07% | 27.93% | Net Selling | |||
| PSN | PARSONS CORP | $6.54B | 106,488,582 | 98.77% | 1.23% | Net Selling | Net Selling | ||
| FBRX | FORTE BIOSCIENCES INC | $371.92M | 12,526,935 | 62.69% | 37.31% | Net Selling | Net Selling | ||
| SPWH | SPORTSMAN's WAREHOUSE HOLDINGS INC | $53.49M | 38,481,095 | 40.84% | 59.16% | Net Buying | Net Buying | ||
| RIOT | RIOT PLATFORMS INC | $5.39B | 371,807,186 | 69.62% | 14.18% | Net Selling | Net Selling | ||
| SI | SHOULDER INNOVATIONS INC | $315.62M | 20,601,684 | 35.52% | 57.57% | Net Buying | Net Buying | ||
| TVRD | TVARDI THERAPEUTICS INC | $37.34M | 9,381,344 | 7.84% | 92.16% | Net Selling | |||
| GLXY | GALAXY DIGITAL INC | $9.37B | 390,610,330 | 25.77% | 1.38% | Net Selling | Net Selling | ||
| IMRX | IMMUNEERING CORP | $364.82M | 64,569,967 | 40.33% | 21.80% | Net Buying | Net Buying | ||
| NUVL | NUVALENT INC | $7.55B | 72,706,715 | 75.85% | 24.15% | Net Selling | Net Selling | ||
| MRP | MILLROSE PROPERTIES INC | $4.88B | 166,003,497 | 64.26% | 0.24% | Net Buying | Net Buying | ||
| MNPR | MONOPAR THERAPEUTICS | $458.63M | 6,682,584 | 18.41% | 81.59% | Net Selling | Net Selling | ||
| FHTX | FOGHORN THERAPEUTICS INC | $296.33M | 56,551,289 | 72.32% | 14.11% | ||||
| CCCC | C4 THERAPEUTICS INC | $196.74M | 96,914,418 | 54.21% | 18.64% | Net Selling | Net Buying | ||
| HOWL | WEREWOLF THERAPEUTICS INC | $33.35M | 48,540,200 | 32.55% | 67.45% | Net Selling | Net Selling | ||
| RAPT | RAPT THERAPEUTICS INC | $936.90M | 27,710,871 | 29.99% | 70.01% | ||||
| CLFD | CLEARFIELD INC | $395.52M | 13,839,096 | 61.08% | 38.92% | Net Selling | Net Selling | ||
| JBIO | JADE BIOSCIENCES INC | $783.45M | 46,004,205 | 62.53% | 37.47% | Net Buying | Net Buying | ||
| APGE | APOGEE THERAPEUTICS INC | $5.37B | 68,320,229 | 87.21% | 8.30% | Net Selling | Net Selling | ||
| IMTX | IMMATICS NV | $1.25B | 121,563,829 | 76.04% | 0.00% | ||||
| SLDB | SOLID BIOSCIENCES INC | $462.79M | 77,910,239 | 55.43% | 44.57% | Net Buying | Net Selling | ||
| EVMN | EVOMMUNE INC | $575.31M | 31,524,093 | 0.00% | 49.18% | Net Buying | Net Buying | ||
| CATX | PERSPECTIVE THERAPEUTICS INC | $204.43M | 74,337,990 | 26.50% | 73.50% | Net Buying | Net Buying | ||
| GPCR | STRUCTURE THERAPEUTICS INC | $3.94B | 182,032,920 | 31.11% | 11.89% | Net Selling | |||
| GHI | GREYSTONE HOUSING IMPACT INVESTORS LP | $161.54M | 23,582,453 | 8.18% | 26.64% | Net Buying | Net Buying | ||
| SNTI | SENTI BIOSCIENCES INC | $31.55M | 26,290,838 | 18.58% | 81.42% | Net Buying | |||
| PRCH | PORCH GROUP INC | $1.11B | 123,683,561 | 61.82% | 38.18% | Net Selling | Net Selling | ||
| OLMA | OLEMA PHARMACEUTICALS INC | $1.92B | 68,659,923 | 72.63% | 27.37% | Net Buying | Net Buying | ||
| NKLR | TERRA INNOVATUM GLOBAL NV | $355.02M | 70,300,948 | 20.46% | 0.00% | ||||
| RAPP | RAPPORT THERAPEUTICS INC | $1.47B | 47,661,138 | 75.35% | 24.65% | Net Selling | Net Selling | ||
| ZURA | ZURA BIO LTD | $277.65M | 65,023,308 | 49.27% | 50.73% | ||||
| LUCK | LUCKY STRIKE ENTERTAINMENT CORP | $1.26B | 139,636,593 | 45.44% | 54.56% | Net Selling | Net Buying | ||
| DNTH | DIANTHUS THERAPEUTICS INC | $1.82B | 42,876,015 | 58.17% | 41.83% | Net Buying | Net Buying | ||
| COYA | COYA THERAPEUTICS INC | $114.88M | 20,924,456 | 22.73% | 10.32% | Net Buying | |||
| KPTI | KARYOPHARM THERAPEUTICS INC | $118.33M | 17,050,876 | 7.70% | 92.30% | Net Selling | Net Selling | ||
| SSTI | SOUNDTHINKING INC | $99.81M | 12,698,453 | 58.20% | 34.82% | Net Selling | Net Selling | ||
| CNTB | CONNECT BIOPHARMA HOLDINGS LTD | $126.90M | 55,903,513 | 2.90% | 0.00% | ||||
| OBIO | ORCHESTRA BIOMED HOLDINGS INC | $245.62M | 56,464,731 | 39.63% | 60.37% | Net Buying | Net Selling | ||
| IVA | INVENTIVA SA | $402.74M | 95,662,391 | 5.34% | 0.00% | ||||
| VKTX | VIKING THERAPEUTICS INC | $3.98B | 113,036,344 | 63.02% | 8.97% | Net Selling | Net Selling | ||
| AVBP | ARRIVENT BIOPHARMA INC | $908.60M | 41,281,361 | 78.59% | 21.41% | Net Buying | |||
| BMEA | BIOMEA FUSION INC | $98.99M | 70,703,639 | 35.45% | 24.59% | Net Buying | Net Buying | ||
| BKR | BAKER HUGHES CO | $44.12B | 986,773,882 | 93.71% | 0.69% | Net Selling | Net Selling | ||
| PRQR | PROQR THERAPEUTICS NV | $238.04M | 107,710,916 | 34.86% | 0.00% | ||||
| AMPL | AMPLITUDE INC | $1.53B | 133,686,174 | 53.65% | 46.35% | Net Selling | Net Selling | ||
| PYXS | PYXIS ONCOLOGY INC | $79.39M | 62,264,215 | 43.09% | 37.50% | ||||
| PYPD | POLYPID LTD | $62.15M | 15,654,129 | 18.10% | 0.00% | ||||
| MPLT | MAPLIGHT THERAPEUTICS INC | $932.42M | 45,373,033 | 0.00% | 53.72% | Net Buying | Net Buying | ||
| PEPG | PEPGEN INC | $372.62M | 68,748,224 | 82.51% | 9.24% | Net Buying | Net Buying | ||
| Q | QNITY ELECTRONICS INC | $16.69B | 209,463,194 | 0.00% | 0.11% | Net Buying | Net Buying | ||
| IFF | INTERNATIONAL FLAVORS & FRAGRANCES INC | $16.84B | 256,096,379 | 77.58% | 22.42% | Net Buying | Net Buying | ||
| TRVI | TREVI THERAPEUTICS INC | $1.67B | 128,230,134 | 41.41% | 58.59% | Net Buying | Net Buying | ||
| GLOO | GLOO HOLDINGS INC | N/A | 72,782,999 | 0.00% | 5.07% | Net Buying | Net Buying | ||
| CRC | CALIFORNIA RESOURCES CORP | $3.65B | 83,711,931 | 87.77% | 12.23% | Net Selling | Net Buying | ||
| RVPH | REVIVA PHARMACEUTICALS HOLDINGS INC | $68.92M | 115,058,619 | 8.25% | 9.28% | ||||
| VREX | VAREX IMAGING CORP | $512.49M | 41,700,000 | 93.34% | 1.83% | Net Selling | Net Selling | ||
| DYN | DYNE THERAPEUTICS INC | $2.84B | 142,824,687 | 83.29% | 16.71% | Net Buying | Net Selling | ||
| NXTC | NEXTCURE INC | $30.50M | 2,679,822 | 5.64% | 94.36% | ||||
| RNAC | CARTESIAN THERAPEUTICS INC | $187.75M | 26,003,606 | 12.83% | 87.17% | Net Buying | Net Buying | ||
| NRIX | NURIX THERAPEUTICS INC | $1.42B | 76,883,436 | 90.92% | 9.08% | Net Selling | Net Selling | ||
| OVID | OVID THERAPEUTICS INC | $104.68M | 71,212,353 | 50.85% | 25.88% | Net Selling | |||
| BRSL | BRIGHTSTAR LOTTERY PLC | $3.14B | 195,000,000 | 44.92% | 0.00% | ||||
| ENOV | ENOVIS CORP | $1.53B | 57,189,381 | 42.12% | 57.88% | Net Selling | Net Buying | ||
| BEP | BROOKFIELD RENEWABLE PARTNERS LP | $7.67B | 285,180,371 | 58.86% | 0.00% | ||||
| ORKA | ORUKA THERAPEUTICS INC | $1.54B | 48,409,232 | 22.87% | 77.13% | Net Buying | Net Buying | ||
| DCO | DUCOMMUN INC | $1.41B | 14,946,052 | 88.54% | 10.35% | Net Selling | Net Selling |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.